Remission in sarcoid uveitis: identification of predictive factors

OBJECTIVE: To identify predictive factors of remission in patients with sarcoid uveitis and to evaluate recurrence rates and patterns following remission. METHODS: Multicentre retrospective study of patients with sarcoid uveitis and a minimum follow-up of 3 years. Remission was defined as the absence of clinical symptoms of sarcoidosis for at least 3 years without treatment. Remission-free Kaplan-Meier survival curves were constructed for selected variables. Cox proportional hazards model was then applied. HRs and 95% CIs were estimated for each variable. Statistical significance was set at the p<0.05 level. Rates and patterns of recurrence after remission were collected and compared with initial presentation. RESULTS: A total of 329 patients were included (62% female, median age 53 years). Remission occurred in 98 (30%) patients after a median follow-up of 6.5 years. Macular oedema at baseline was associated with a lower likelihood of remission (HR, 0.594, 95% CI 0.342 to 0.996, p=0.043), whereas pulmonary involvement at baseline was associated with a higher likelihood of remission (HR, 1.588, 95% CI 1.047 to 2.419, p=0.032). Recurrence after remission occurred in 6 of 98 patients (6%), with a median time to recurrence of 46 months after remission. At recurrence, patients predominantly had anterior uveitis (83%) and shared similar anatomical patterns with their initial presentation. CONCLUSIONS: Approximately one in three patients with sarcoid uveitis achieved remission. Macular oedema at baseline was associated with delayed remission, while lung involvement at baseline was associated with faster remission. Recurrence after remission was uncommon and typically mirrored the initial uveitis phenotype.

Authors

Institutions

Publication Details

Journal
British Journal of Ophthalmology
Published
2026-04-01
DOI
https://doi.org/10.1136/bjo-2025-328902
Primary Topic
Sarcoidosis and Beryllium Toxicity Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Remission in sarcoid uveitis: identification of predictive factors

R. Jacquot, Fabien Subtil, Thomas El Jammal, S. Abramowicz et al.
British Journal of Ophthalmology
Sarcoidosis and Beryllium Toxicity Research
article

Remission in sarcoid uveitis: identification of predictive factors

R. Jacquot, Fabien Subtil, Thomas El Jammal, S. Abramowicz, A. Siriphanh, M. Cargnelutti, Laurent Pérard, C. Burillon, Laurent Kodjikian, Pascal Sève
article en

Abstract

OBJECTIVE: To identify predictive factors of remission in patients with sarcoid uveitis and to evaluate recurrence rates and patterns following remission. METHODS: Multicentre retrospective study of patients with sarcoid uveitis and a minimum follow-up of 3 years. Remission was defined as the absence of clinical symptoms of sarcoidosis for at least 3 years without treatment. Remission-free Kaplan-Meier survival curves were constructed for selected variables. Cox proportional hazards model was then applied. HRs and 95% CIs were estimated for each variable. Statistical significance was set at the p<0.05 level. Rates and patterns of recurrence after remission were collected and compared with initial presentation. RESULTS: A total of 329 patients were included (62% female, median age 53 years). Remission occurred in 98 (30%) patients after a median follow-up of 6.5 years. Macular oedema at baseline was associated with a lower likelihood of remission (HR, 0.594, 95% CI 0.342 to 0.996, p=0.043), whereas pulmonary involvement at baseline was associated with a higher likelihood of remission (HR, 1.588, 95% CI 1.047 to 2.419, p=0.032). Recurrence after remission occurred in 6 of 98 patients (6%), with a median time to recurrence of 46 months after remission. At recurrence, patients predominantly had anterior uveitis (83%) and shared similar anatomical patterns with their initial presentation. CONCLUSIONS: Approximately one in three patients with sarcoid uveitis achieved remission. Macular oedema at baseline was associated with delayed remission, while lung involvement at baseline was associated with faster remission. Recurrence after remission was uncommon and typically mirrored the initial uveitis phenotype.

British Journal of Ophthalmology
Université Claude Bernard Lyon 1 (FR), Centre National de la Recherche Scientifique (FR), Hôpital de la Croix-Rousse (FR), Hospices Civils de Lyon (FR), Hôpital Edouard Herriot (FR), Laboratoire de Biométrie et Biologie Evolutive (FR), Centre Hospitalier Saint-Joseph Saint-Luc (FR)
Good health and well-being
Openalex Percentile: Top 32%
Sarcoidosis and Beryllium Toxicity Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.